
Vizgen secures $48M financing led by ARCH Venture Partners, M Ventures, and Northpond Ventures to expand its operations globally.
WALTHAM, Massachusetts - Vizgen, Inc., a prominent player in spatial multi-omics, has recently completed a $48 million financing round. ARCH Venture Partners spearheaded the funding, joined by co-leaders M Ventures and Northpond Ventures, along with contributions from the company's current backers. The capital injection will facilitate the realization of Vizgen's innovative plans, enhance its global research support capabilities, and bolster manufacturing activities. The company is credited with spearheading the field of single-cell spatial genomics.

